image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 0.1914
0.737 %
$ 10.6 M
Market Cap
-0.11
P/E
BALANCE SHEET
12.8 M ASSETS
-6.32%
3.82 M LIABILITIES
-56.48%
9.14 M EQUITY
84.66%
BALANCE SHEET DECOMPOSITION
Balance Sheet Applied DNA Sciences, Inc.
image
Current Assets 8.05 M
Cash & Short-Term Investments 6.43 M
Receivables 362 K
Other Current Assets 1.25 M
Non-Current Assets 4.74 M
Long-Term Investments 0
PP&E 1.29 M
Other Non-Current Assets 3.45 M
Current Liabilities 2.4 M
Accounts Payable 1.17 M
Short-Term Debt 546 K
Other Current Liabilities 686 K
Non-Current Liabilities 1.42 M
Long-Term Debt 193 K
Other Non-Current Liabilities 1.23 M

Balance Sheet

Millions
Sep-2024 Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Sep-2012 Sep-2011 Sep-2010 Sep-2009 Sep-2008 Sep-2007 Sep-2006 Sep-2005 Sep-2004 Sep-2003 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997
ASSETS
Cash & Cash Equivalents 6.4 7.2 15.2 6.6 7.8 0.6 1.7 3.0 4.5 7.3 1.4 6.4 0.7 2.7 17.6 K 0.2 0.1 25.2 K 1.2 31.2 K 1.83 K 0.2 135 0 0 0 0
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.4 0.3 3.1 2.8 0.2 0.8 1.5 2.6 6.4 3.9 0.8 0.7 0.3 0.2 63 K 47.3 K 75.2 K 0 18 K 12.4 K 0 0 0 0 0 0 0
Inventory 0.4 0.3 0.6 1.4 0.5 0.1 0.2 0.3 0.3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.8 0.4 2.1 1.1 1.2 1.2 1.3 0.7 0.4 0.6 0.1 0.2 80 K 76.3 K 0.2 79.4 K 83.3 K 0.1 0.1 0 0 0 0 0 0 0 0
Total Current Assets 8.0 8.1 19.9 11.3 9.1 2.1 4.0 6.2 11.4 11.5 2.4 7.2 1.1 3.0 0.2 0.3 0.3 0.5 1.4 43.6 K 1.83 K 0.2 135 0 0 0 0
PP&E 1.3 2.1 2.2 3.0 1.3 0.2 0.4 0.5 0.8 0.6 0.6 0.7 0.2 89.1 K 3.76 K 11.7 K 63.7 K 0.1 0.2 8.06 K 28.1 K 0 0 0 0 0 0
Intangible Assets 2.7 2.7 0 0 0.6 0.7 0.9 1.0 1.5 1.6 0.3 0.4 0 0.3 0.6 1.0 1.4 1.7 2.1 9.1 28.2 K 13.9 K 0 0 0 0 0
Goodwill 0 0 0 0 0.3 0.3 0.3 0.3 0.3 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.8 0.8 99 K 95 K 95.1 K 0.2 62.3 K 61.6 K 1.6 1.6 0.2 51.3 K 36.3 K 0.1 0.5 0.2 0.1 43.3 K 1.1 14.3 K 23.6 K 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 12.8 13.7 22.3 14.4 11.3 3.6 5.6 8.2 15.6 15.6 3.5 8.4 1.3 3.5 1.4 1.5 1.8 2.4 4.7 9.2 81.6 K 0.2 135 0 0 0 0
LIABILITIES
Accounts Payable 1.2 1.1 1.7 1.4 1.3 1.2 0.5 0.4 1.5 1.2 1.1 0.6 0.5 0.2 0.7 0.6 0.4 1.2 0.3 2.2 1.8 0.5 0 1.28 K 1.28 K 963 2.23 K
Short Term Debt 0.5 0.5 0 0 1.8 0 0 0 0 0 1.8 0 0 3.7 1.8 2.4 3.1 0.7 4.2 0.4 2.8 0 0 0 0 0 3 K
Other Current Liabilities 0.6 1.2 1.9 1.6 0.7 0.4 0.5 0.6 0.7 1.1 0.4 0.3 0.1 0.6 0.3 0.3 12.4 12.4 5.2 0 0.2 0.2 0 1.28 K 320 4.27 K 1.58 K
Total Current Liabilities 2.4 2.8 4.2 3.3 4.3 2.2 2.8 1.3 4.1 2.7 3.9 1.1 0.6 4.5 2.8 3.3 15.9 14.4 9.7 2.6 4.8 0.7 0 1.28 K 963 5.23 K 3.65 K
Long Term Debt 0.2 0.7 0 0 0.5 1.5 1.6 0 0 0 0 0 0 0 0.2 0 0 0 4.5 0 0 88.5 K 0 0 0 0 0
Deferred Tax Income 0.7 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0.5 4.3 5.2 31.5 K 0.8 0.6 0.5 0 0.2 0.3 1.1 2.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 3.8 8.8 9.4 3.3 5.6 4.4 4.9 1.3 5.2 3.0 5.0 3.8 0.6 4.5 3.0 3.3 15.9 14.4 14.3 2.6 4.8 0.8 0 1.28 K 963 5.23 K 3.65 K
EQUITY
Common Stock 10.3 K 13.7 K 12.9 K 7.49 K 5.14 K 1.2 K 30.1 K 27.4 K 24.1 K 21.5 K 13.9 K 0.8 0.6 0.5 0.3 0.3 0.2 0.2 0.1 0.1 12.0 1.78 K 1.02 K 15 15 146 196
Retained Earnings (309.7) (302.4) (292.5) (284.1) (269.8) (256.8) (248.4) (236.7) (223.8) (211.6) (199.8) (186.7) (169.0) (161.9) (151.3) (143.4) (147.4) (140.6) (92.3) (75.4) (22.8) (3.5) (0.8) (0.8) (0.8) (0.8) (0.8)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (2.0) (1.7) (1.3) (0.9) (0.8) (0.4) (0.3) (0.2) (0.2) (0.2) (0.1) 82.8 K 20.9 K 20 K 1 K 0.3 0 0 0 0 0
Total Equity 9.0 4.9 12.9 11.1 5.7 (0.8) 0.8 6.9 10.4 12.6 (1.5) 4.6 0.8 (1.0) (1.6) (1.7) (14.0) (11.9) (9.6) 6.6 (4.7) (0.6) 135 1.28 K 963 5.23 K 3.65 K
Total Liabilities and Equity 12.8 13.7 22.3 14.4 11.3 3.6 5.6 8.2 15.6 15.6 3.5 8.4 1.3 3.5 1.4 1.5 1.8 2.4 4.7 9.2 81.6 K 0.2 135 0 0 0 0
SHARES OUTSTANDING
Common Shares Outstanding 4.0 0.7 0.4 0.3 0.2 46.1 K 36.9 K 33 K 29.6 K 23.7 K 16.9 K 14.7 K 0.2 0.2 0.1 0.1 79.8 K 56.3 K 48.7 K 26.6 K 8.68 K 5.4 K 1.18 K 60 60 60 81